00
GC Pharma
006280.KS·KRXYongin KRFounded 19674,000 employees
Mid CappharmaPublicHematologyInfectious Disease
Platform: Plasma & Vaccine
Market Cap
$3B
All Drugs
3
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (006280.KS)
Loading 006280.KS stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Voxafutibatinib | 006-4655 | Phase 1/2 | 1 | GPRC5D | PSPCRC | ||
| 006-2012 | 006-2012 | Phase 1/2 | 2 | BCL-2 | IPFCLL | ||
| 006-348 | 006-348 | Phase 1/2 | 1 | CD38 | FabryProstate Ca |
SEC Filings & Financial Documents
SEC filings are not available for KRX-listed companies.
GC Pharma trades on KRX (KR). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)